Curative Operating Cycle from 2010 to 2026
| CUBT Stock | USD 0.01 0.0005 11.11% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 1.6 K | Current Value 1.7 K | Quarterly Volatility 727.1539905 |
Check Curative Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Curative Biotechnology's main balance sheet or income statement drivers, such as Depreciation And Amortization of 111.3 K, Interest Expense of 1.4 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 55.01, Dividend Yield of 0.0 or Days Sales Outstanding of 267. Curative financial statements analysis is a perfect complement when working with Curative Biotechnology Valuation or Volatility modules.
Curative | Operating Cycle | Build AI portfolio with Curative Stock |
Latest Curative Biotechnology's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Curative Biotechnology over the last few years. It is Curative Biotechnology's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Curative Biotechnology's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Curative Operating Cycle Regression Statistics
| Arithmetic Mean | 1,220 | |
| Geometric Mean | 818.09 | |
| Coefficient Of Variation | 59.62 | |
| Mean Deviation | 669.95 | |
| Median | 1,762 | |
| Standard Deviation | 727.15 | |
| Sample Variance | 528,753 | |
| Range | 1.7K | |
| R-Value | 0.79 | |
| Mean Square Error | 211,254 | |
| R-Squared | 0.63 | |
| Significance | 0.0002 | |
| Slope | 113.88 | |
| Total Sum of Squares | 8.5M |
Curative Operating Cycle History
About Curative Biotechnology Financial Statements
Curative Biotechnology shareholders use historical fundamental indicators, such as Operating Cycle, to determine how well the company is positioned to perform in the future. Although Curative Biotechnology investors may analyze each financial statement separately, they are all interrelated. The changes in Curative Biotechnology's assets and liabilities, for example, are also reflected in the revenues and expenses on on Curative Biotechnology's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 1.6 K | 1.7 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Curative Stock Analysis
When running Curative Biotechnology's price analysis, check to measure Curative Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biotechnology is operating at the current time. Most of Curative Biotechnology's value examination focuses on studying past and present price action to predict the probability of Curative Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biotechnology's price. Additionally, you may evaluate how the addition of Curative Biotechnology to your portfolios can decrease your overall portfolio volatility.